---
bio-current:
  name-cn: 斯科特·卡特
  name-en: Scott Carter
  email: 
    - carter.scott@jimmy.harvard.edu # 如果有多个邮箱，请都填写上
  sex: male
  birth-date: # yyyy 到年即可
  university: Harvard University 
  school: Dept, of Biostatistics [https://www.hsph.harvard.edu/biostatistics/] # 格式：学院名称[学院官网链接]
  major: Computational Biology
  title-raw: Assistant Professor # 主页原始字符串
  title: Assistant Professor
  interests: # 分点罗列，依次以 ‘-’ 开头
  homepage: 
    - https://www.hsph.harvard.edu/scott-carter/ # 如果有多个主页，请都填写上
  github: 
  googlescholar: https://scholar.google.com/citations?hl=zh-CN&user=EsIyIQsAAAAJ 
  aminer: # 从这里查找 https://www.aminer.org/search/person
  status: 在职
  last-update: 2021-08-02 # yyyy-mm-dd 最近一次信息更新日期
edu-phd:  # 读博经历
  university: 
  school: 
  email: 
  date-start: 
  date-end: 
  advisor: # 格式：导师名 [邮箱/网址]
  degree: # phd
edu-master: # 硕士经历，没有或找不到，可不填
  university: 
  school: 
  date-start: 
  date-end: 
  advisor:
edu-bachelor:  # 本科经历，没有或找不到，可不填
  university: 
  school: 
  major: 
  date-start: 
  date-end: 
page-other:   # 其他有用的链接，部分可从学者主页子栏目获得
  publication: https://connects.catalyst.harvard.edu/Profiles/display/Person/5206
  research: 
  software: 
  project: 
  blog: 
  arxiv: 
  linkedin: 
  weibo:
  twitter:
  wikipedia:
  baidu-baike:
collaboration: # 合作研究，关注学者和其他哪些学科的人合作，具体研究哪些主题
  - 
    with: # 合作者
    project: # 研究主题
  - 
    with: 
    project: 
group: # 所属团队，学者可能有不同的兴趣小组，可以列上去
job-faculty-1: # 所属机构，若有多个增加编号即可，字段填写参看示例文件
  university: Harvard University
  school: Harvard T.H. Chan School of Public Health
  major: Biostatistics
  email: carter.scott@jimmy.harvard.edu
  homepage: https://www.hsph.harvard.edu/scott-carter/ # 机构内学者主页
  date-start: 
  title: Assistant Professor of Computational Biology
  type: 
job-post-doc: # 博士后研究员，字段填写参看示例文件，若无可不填写
  university: 
  school: 
  email: 
  date-start: 
  date-end: 
  advisor: 
---

# Profile

![Scott Carter](https://connects.catalyst.harvard.edu/Profiles/profile/Modules/CustomViewPersonGeneralInfo/PhotoHandler.ashx?NodeID=59903837)

# Biography[English]

# Biography[中文]

# Interests[English]

# Interests[中文]

# Education[English]

# Education[中文]

# Awards[English]

# Awards[中文]

# Talks[English]

# Talks[中文]

# Work experience[English]

# Work experience[中文]

# Publication[English]

- White MD, Klein RH, Shaw B, Kim A, Subramanian M, Mora JL, Giobbie-Hurder A, Nagabhushan D, Jain A, Singh M, Kuter BM, Nayyar N, Bertalan MS, Stocking JH, Markson SC, Lastrapes M, Alvarez-Breckenridge C, Cahill DP, Gydush G, Rhoades J, Rotem D, Adalsteinsson VA, Mahar M, Kaplan A, Oh K, Sullivan RJ, Gerstner E, **Carter SL**, Brastianos PK, Detection of Leptomeningeal Disease Using Cell-Free DNA From Cerebrospinal Fluid, 2021
- Kennedy AL, Myers KC, Bowman J, Gibson CJ, Camarda ND, Furutani E, Muscato GM, Klein RH, Ballotti K, Liu S, Harris CE, Galvin A, Malsch M, Dale D, Gansner JM, Nakano TA, Bertuch A, Vlachos A, Lipton JM, Castillo P, Connelly J, Churpek J, Edwards JR, Hijiya N, Ho RH, Hofmann I, Huang JN, Keel S, Lamble A, Lau BW, Norkin M, Stieglitz E, Stock W, Walkovich K, Boettcher S, Brendel C, Fleming MD, Davies SM, Weller EA, Bahl C, **Carter SL**, Shimamura A, Lindsley RC, Distinct genetic pathways define pre-malignant versus compensatory clonal hematopoiesis in Shwachman-Diamond syndrome, 2021
- Brastianos PK, Lee EQ, Cohen JV, Tolaney SM, Lin NU, Wang N, Chukwueke U, White MD, Nayyar N, Kim A, Alvarez-Breckenridge C, Krop I, Mahar MK, Bertalan MS, Shaw B, Mora JL, Goss N, Subramanian M, Nayak L, Dietrich J, Forst DA, Nahed BV, Batchelor TT, Shih HA, Gerstner ER, Moy B, Lawrence D, Giobbie-Hurder A, **Carter SL**, Oh K, Cahill DP, Sullivan RJ, Publisher Correction: Single-arm, open-label phase 2 trial of pembrolizumab in patients with leptomeningeal carcinomatosis, 2021
- Brastianos PK, Lee EQ, Cohen JV, Tolaney SM, Lin NU, Wang N, Chukwueke U, White MD, Nayyar N, Kim A, Alvarez-Breckenridge C, Krop I, Mahar MK, Bertalan MS, Shaw B, Mora JL, Goss N, Subramanian M, Nayak L, Dietrich J, Forst DA, Nahed BV, Batchelor TT, Shih HA, Gerstner ER, Moy B, Lawrence D, Giobbie-Hurder A, **Carter SL**, Oh K, Cahill DP, Sullivan RJ, Single-arm, open-label phase 2 trial of pembrolizumab in patients with leptomeningeal carcinomatosis, 2021
- Gstalder C, Liu D, Miao D, Lutterbach B, DeVine AL, Lin C, Shettigar M, Pancholi P, Buchbinder EI, **Carter SL**, Manos MP, Rojas-Rudilla V, Brennick R, Gjini E, Chen PH, Lako A, Rodig S, Yoon CH, Freeman GJ, Barbie DA, Hodi FS, Miles W, Van Allen EM, Haq R, Inactivation of Fbxw7 Impairs dsRNA Sensing and Confers Resistance to PD-1 Blockade, 2021

# Publication[中文]

# Information Reference

-  homepage: https://www.hsph.harvard.edu/scott-carter/
-  googlescholar: https://scholar.google.com/citations?hl=zh-CN&user=EsIyIQsAAAAJ 
-  aminer: 

# Notes